When evaluating animal survival over an extended period, both BCG and rBCG treatments significantly prolonged survival compared with the untreated group, with a clear trend toward improved survival in rBCG-treated mice (Figure 5 G).
← all excerpts
rBCG-LTAK63 Outperforms BCG in Bladder Cancer Immunotherapy: Dendritic and T Cell Coordination Drives Superior Tumor Control in a Mouse Model.
1
—
—